Search research articles
Contact Us
Filters
Showing results (231-240 of 408) with videos related to
Page
of 41
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
September 14, 2006
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis
Stefano Taddei, Nadia Caraccio, Agostino Virdis, et al.
Diabetologia
|
October 14, 2018
Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes
Daniela Guarino, Diego Moriconi, Andrea Mari, et al.
Autoimmunity
|
October 16, 2008
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis
Alessandro Antonelli, Poupak Fallahi, Andrea Delle Sedie, et al.
Diabetes
|
July 8, 2024
GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss
Giuseppe Della Pepa, Bárbara G Patrício, Fabrizia Carli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 24, 2005
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists
Alessandro Antonelli, Mario Rotondi, Silvia Martina Ferrari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 7, 2003
Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study
Patricia Iozzo, Fabian Geisler, Vesa Oikonen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 3, 2003
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control
Patricia Iozzo, Kirsti Hallsten, Vesa Oikonen, et al.
Experimental Cell Research
|
May 14, 2011
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease
Alessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 study
Ele Ferrannini, Simona Baldi, Juan P Frías, et al.
Immunobiology
|
September 5, 2012
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists
Alessandro Antonelli, Silvia Martina Ferrari, Caterina Mancusi, et al.
Page
of 41
Search research articles
Search
Showing results (231-240 of 408) with videos related to
Sort By:
Page
of 41
The Journal of Clinical Endocrinology and Metabolism
|
September 14, 2006
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis
Stefano Taddei, Nadia Caraccio, Agostino Virdis, et al.
Diabetologia
|
October 14, 2018
Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes
Daniela Guarino, Diego Moriconi, Andrea Mari, et al.
Autoimmunity
|
October 16, 2008
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis
Alessandro Antonelli, Poupak Fallahi, Andrea Delle Sedie, et al.
Diabetes
|
July 8, 2024
GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss
Giuseppe Della Pepa, Bárbara G Patrício, Fabrizia Carli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 24, 2005
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists
Alessandro Antonelli, Mario Rotondi, Silvia Martina Ferrari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 7, 2003
Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study
Patricia Iozzo, Fabian Geisler, Vesa Oikonen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 3, 2003
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control
Patricia Iozzo, Kirsti Hallsten, Vesa Oikonen, et al.
Experimental Cell Research
|
May 14, 2011
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease
Alessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 study
Ele Ferrannini, Simona Baldi, Juan P Frías, et al.
Immunobiology
|
September 5, 2012
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists
Alessandro Antonelli, Silvia Martina Ferrari, Caterina Mancusi, et al.
Page
of 41